AI for Alzheimer’s
The OpenAI Foundation is working to finalize more than $100 million in initial grants across six research institutions to support AI for Alzheimer’s research
AI for Alzheimer’s April 8, 2026 AI for Alzheimer’s By Jacob Trefethen Why focus on Alzheimer’s? Alzheimer’s disease is one of the hardest unsolved problems in medicine, and one of the most devastating. It kills millions of people, places a huge burden on families, and still defies much of what medicine can do today. At the OpenAI Foundation, we want to change that by using advanced AI to accelerate the science of preventing and treating the disease. 1 As a first step, we are working to finalise more than $100 million in grants this month, across six research institutions, to support and acc
saved by
related reading
- Drug Discovery Has No Magic Wandsa16z.news
- Dario Amodei — Machines of Loving Gracedarioamodei.com
- Dario Amodei — Machines of Loving Gracedarioamodei.com
- Dario Amodei — Machines of Loving Gracedarioamodei.com
- Gap Mapgap-map.org
- Using Interpretability to Identify a Novel Class of Alzheimer's Biomarkersgoodfire.ai
- Contrary Research on X: "The Virtual Cell Revolution" / Xx.com
- Update on the OpenAI Foundationopenaifoundation.org
- Biomarkers for Alzheimer’s Disease in the Current State: A Narrative Review - PMCncbi.nlm.nih.gov
- The amyloid hypothesis in Alzheimer disease: new insights from new therapeuticsnature.com
- What will it take for AI to change drug discovery?writingruxandrabio.com
- A new golden age of discoveryaipolicyperspectives.com